QSAR and Molecular Docking Directed Synthesis and Preliminary Evaluation of Novel Non-Nucleoside HCV NS5B Polymerase Inhibitors

Publisher： Bentham Science Publishers

E-ISSN： 2211-3533|15|1|52-56

ISSN： 2211-3525

Source： Anti-Infective Agents, Vol.15, Iss.1, 2017-04, pp. : 52-56

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Non-Nucleoside Inhibitors of NS5B Polymerase Binding to Allosteric Sites: 3DQSAR and Molecular Docking Studies

By  

Current Medicinal Chemistry, Vol. 15, Iss. 15, 2008-06 ,pp. : 1462-1477

Bentham Science Publishers

Access to resources Recommend Favorite

Comparative QSAR Studies on the Novel Series of Thiazolones and Tetrazole Derivatives as HCV NS5B Polymerase Allosteric Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 6, Iss. 4, 2009-06 ,pp. : 286-297

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR and Molecular Modeling Studies on a Series of Indole-based Pyridone Analogues as HCV NS5B Polymerase Inhibitors

By  

Letters in Drug Design & Discovery, Vol. 13, Iss. 8, 2016-10 ,pp. : 757-770

Bentham Science Publishers

Access to resources Recommend Favorite

Studies of Benzothiadiazine Derivatives as Hepatitis C Virus NS5B Polymerase Inhibitors Using 3D-QSAR, Molecular Docking and Molecular Dynamics

By  

Current Medicinal Chemistry, Vol. 17, Iss. 25, 2010-09 ,pp. : 2788-2803

Bentham Science Publishers

Access to resources Recommend Favorite

Insight into the Structural Requirements of Benzothiadiazine Scaffold-Based Derivatives as Hepatitis C Virus NS5B Polymerase Inhibitors Using 3D-QSAR, Molecular Docking and Molecular Dynamics

By  

Current Medicinal Chemistry, Vol. 18, Iss. 26, 2011-09 ,pp. : 4019-4028

Bentham Science Publishers

Access to resources Recommend Favorite